Share-based Payment Arrangement, Expense of IDEXX LABORATORIES INC /DE from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IDEXX LABORATORIES INC /DE quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $14,400,000, a 9.4% decline year-over-year.
  • IDEXX LABORATORIES INC /DE Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $58,195,000, a 5% decline year-over-year.
  • IDEXX LABORATORIES INC /DE annual Share-based Payment Arrangement, Expense for 2024 was $60,295,000, a 0.93% increase from 2023.
  • IDEXX LABORATORIES INC /DE annual Share-based Payment Arrangement, Expense for 2023 was $59,739,000, a 20% increase from 2022.
  • IDEXX LABORATORIES INC /DE annual Share-based Payment Arrangement, Expense for 2022 was $49,770,000, a 32% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

IDEXX LABORATORIES INC /DE Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $58,195,000 $14,400,000 -$1,500,000 -9.4% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $59,695,000 $14,900,000 -$800,000 -5.1% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $60,495,000 $14,600,000 +$200,000 +1.4% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $60,295,000 $14,295,000 -$944,000 -6.2% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $61,239,000 $15,900,000 +$700,000 +4.6% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $60,539,000 $15,700,000 +$300,000 +1.9% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $60,239,000 $14,400,000 +$500,000 +3.6% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $59,739,000 $15,239,000 +$1,869,000 +14% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $57,870,000 $15,200,000 +$2,300,000 +18% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $55,570,000 $15,400,000 +$3,100,000 +25% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $52,470,000 $13,900,000 +$2,700,000 +24% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q4 2022 $49,770,000 $13,370,000 +$3,615,000 +37% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
Q3 2022 $46,155,000 $12,900,000 +$3,400,000 +36% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $42,755,000 $12,300,000 +$2,700,000 +28% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $40,055,000 $11,200,000 +$2,300,000 +26% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $37,755,000 $9,755,000 +$1,804,000 +23% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $35,951,000 $9,500,000 +$1,600,000 +20% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $34,351,000 $9,600,000 +$1,800,000 +23% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $32,551,000 $8,900,000 +$1,600,000 +22% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $30,951,000 $7,951,000 -$8,727,000 -52% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q3 2020 $39,678,000 $7,900,000 -$1,500,000 -16% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $41,178,000 $7,800,000 +$900,000 +13% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $40,278,000 $7,300,000 +$1,000,000 +16% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $39,278,000 $16,678,000 +$10,521,000 +171% 01 Oct 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
Q3 2019 $28,757,000 $9,400,000 +$2,900,000 +45% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $25,857,000 $6,900,000 +$400,000 +6.2% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $25,457,000 $6,300,000 +$300,000 +5% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $25,157,000 $6,157,000 01 Oct 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
Q3 2018 $6,500,000 +$400,000 +6.6% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $6,500,000 +$500,000 +8.3% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $6,000,000 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q3 2017 $6,100,000 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018 2018 Q3
Q2 2017 $6,000,000 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2

IDEXX LABORATORIES INC /DE Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $60,295,000 +$556,000 +0.93% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $59,739,000 +$9,969,000 +20% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $49,770,000 +$12,015,000 +32% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $37,755,000 +$6,804,000 +22% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $30,951,000 -$8,327,000 -21% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $39,278,000 +$14,121,000 +56% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $25,157,000 +$1,640,000 +7% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $23,517,000 +$3,626,000 +18% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $19,891,000 +$7,000 +0.04% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $19,884,000 +$1,785,000 +9.9% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $18,099,000 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.